Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity

Gynecological Endocrinology

Volumn 29, Issue 2, 2013, Pages 152-155

  Aydogdu, Aydogan ^a   Tasci, Ilker ^a   Kucukerdonmez, Ozge ^a   Tapan, Serkan ^a   Aydogdu, Sebnem ^b   Aydogan, Umit ^a   Sonmez, Alper ^a   Yazici, Mahmut ^c   Azal, Omer ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANKARA MEVKI MILITARY HOSPITAL   (Turkey)

^c ETIMESGUT MILITARY HOSPITAL   (Turkey)

Author keywords

Adiponectin; Insulin resistance; Polycystic ovary syndrome; Skinfold thickness

Indexed keywords

ADIPONECTIN;

ADULT; ARM CIRCUMFERENCE; ARTICLE; BICEPS BRACHII MUSCLE; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; FAT FREE MASS; FEMALE; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; IMPEDANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SHOULDER; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; TRICEPS BRACHII MUSCLE; TRUNK;

ABDOMEN; ADIPONECTIN; ADIPOSE TISSUE; ADIPOSITY; ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; MUSCLE DEVELOPMENT; POLYCYSTIC OVARY SYNDROME; REGRESSION ANALYSIS; SKINFOLD THICKNESS; SUBCUTANEOUS FAT; TURKEY; YOUNG ADULT;

EID: 84871462513     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.708802     Document Type: Article

References (24)

1. Koiou E, Tziomalos K, Dinas K, Katsikis I, Kalaitzakis E, Delkos D, Kandaraki EA, Panidis D. The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J 2011;58:237-246.
2. Marshall JC, Dalkin A, Haisenleder DY. Gonadotropin releasing hormone puls: Regulators of gonadotropin synthesis and ovulatory cycles. Revent Prog Horm Res 1991;47: 155.
3. Hahn S, Tan S, Sack S, Kimmig R, Quadbeck B, Mann K, Janssen OE. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2007;115:130-135. (Pubitemid 46408122)
4. Rossi B, Sukalich S, Droz J, Griffin A, Cook S, Blumkin A, Guzick DS, Hoeger KM. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2008;93:4780-4786.
5. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579-1585. (Pubitemid 27411233)
6. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am 2008;37:635-646, viii-ix.
7. Guo Z, Hensrud DD, Johnson CM, Jensen MD. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 1999;48:1586-1592. (Pubitemid 29356867)
8. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
9. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
11. Pugeat M, Ducluzeau PH. Insulin resistance, polycystic ovary syndrome and metformin. Drugs 1999;58 Suppl 1:41-6; discussion 75.
12. Wehr E, M?ler R, Horejsi R, Giuliani A, Kopera D, Schweighofer N, Groselj-Strele A, et al. Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome. Wien Klin Wochenschr 2009;121:262-269.
13. Volafova J, Bray GA. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments and visceral adipose tissue in the metabolic components of obesity. Metabolism 2001;50:425-435. (Pubitemid 32321951)
14. dos Santos RE, Aldrighi JM, Lanz JR, Ferezin PC, Marone MM. Relationship of body fat distribution by waist circumference, dualenergy X-ray absorptiometry and ultrasonography to insulin resistance by homeostasis model assessment and lipid profile in obese and non-obese postmenopausal women. Gynecol Endocrinol 2005;21:295-301. (Pubitemid 43041752)
15. Capkova-Parizkova J. Measurement of subcutaneous fat by a caliper. Cesk Pediatr 1958;13:310-311.
16. Ludescher B, Machann J, Eschweiler GW, Vanh?en S, Maenz C, Thamer C, Claussen CD, Schick F. Correlation of fat distribution in whole body MRI with generally used anthropometric data. Invest Radiol 2009;44:712-719.
17. Ng J, Rohling R, Lawrence PD. Automatic measurement of human subcutaneous fat with ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control 2009;56:1642-1653.
18. Eston RG, Rowlands AV, Charlesworth S, Davies A, Hoppitt T. Prediction of DXA-determined whole body fat from skinfolds: importance of including skinfolds from the thigh and calf in young, healthy men and women. Eur J Clin Nutr 2005;59:695-702. (Pubitemid 40716136)
19. Cosar E, U?k K, Akg? L, K?en G, Sahin FK, Arioz DT, Bas O. Body fat composition and distribution in women with polycystic ovary syndrome. Gynecol Endocrinol 2008;24:428-432.
20. Frederiksen L, Nielsen TL, Wraae K, Hagen C, Frystyk J, Flyvbjerg A, Brixen K, Andersen M. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab 2009;94:4010-4015.
21. Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R, Fuchs D. Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem 2010;17:4511-4520.
22. Faloia E, Canibus P, Gatti C, Frezza F, Santangelo M, Garrapa GG, Boscaro M. Body composition, fat distribution and metabolic characteristics in lean and obese women with polycystic ovary syndrome. J Endocrinol Invest 2004;27:424-429. (Pubitemid 38961252)
23. Douchi T, Oki T, Yamasaki H, Kuwahata R, Nakae M, Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet Gynecol 2001;98:445-449.
24. Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol 2009;161:583-589.